Evidence map›Paper›PMID 20664695›Full record

ArticleMolecular vision2010

The role of signaling pathways in the expansion of corneal epithelial cells in serum-free B27 supplemented medium.

Sasirekha Krishnan, Shruthi Lakshmanan, Geetha Krishnan Iyer, Krishnan UmaMaheswari, Subramanian Krishnakumar

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Molecular vision, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sasirekha KrishnanL&T Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai, India. krishnan.sasirekha@gmail.com
Shruthi Lakshmanan
Geetha Krishnan Iyer
Krishnan UmaMaheswari
Subramanian Krishnakumar
Sankara Nethralaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo study the influence of serum-free B27 supplemented culture medium on corneal epithelial cells from limbal explants.

methodsHuman limbal tissues obtained from cadaveric donor eyes were used in this study. The morphological characteristics of cultivated epithelial cells were analyzed by phase contrast microscopy. Growth kinetics, bromodeoxyuridine (BrdU) labeling cell proliferation assay, and reverse transcriptase PCR (RT-PCR) for limbus and corneal markers were studied in serum-dependent and serum-free B27 supplemented corneal epithelial culture. The signaling pathway genes were analyzed by RT(2) qPCR profiler array.

resultsThe corneal epithelial cells morphology and mRNA expression of markers were similar in both the serum-dependent and serum-free B27 supplemented culture. The growth and proliferation of the serum-free B27 supplemented culture was significantly higher than that of the serum-dependent culture. The wnt, hedgehog, survival, NFkB, Jak-Stat, and calcium protein kinase C pathways were highly expressed in the serum-free B27 supplemented corneal epithelial culture.

conclusionsMost signaling pathway genes are upfolded by B27 supplementation in the corneal epithelial cell culture; it could be an efficient replacement for serum.

Indexed as

AgedAged, 80 and overBromodeoxyuridineCell MovementCell ProliferationCells, CulturedCulture Media, Serum-FreeEpithelial CellsEpithelium, CornealGene Expression ProfilingGene Expression RegulationHumansKineticsReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSignal TransductionBromodeoxyuridineCulture Media, Serum-FreeRNA, Messenger

Identifiers

PMID20664695
PMCPMC2901195
OpenAlexW174729135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.